Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Leukemia, Myeloid, Acute 32Leukemia 21Lymphoma 15Prostatic Neoplasms 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 10Lymphoma, Large B-Cell, Diffuse 9Leukemia, Monocytic, Acute 8Recurrence 7Lymphoma, Mantle-Cell 7Leukemia, Myelomonocytic, Acute 7Leukemia, Lymphocytic, Chronic, B-Cell 7Leukemia, Erythroblastic, Acute 7Congenital Abnormalities 7Myelodysplastic Syndromes 6Leukemia, Megakaryoblastic, Acute 6Lymphoma, Large-Cell, Immunoblastic 5Hodgkin Disease 4Burkitt Lymphoma 4Breast Neoplasms 4Blast Crisis 4Multiple Myeloma 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Biphenotypic, Acute 2HIV Infections 2Drug-Related Side Effects and Adverse Reactions 2

Interventions

Paclitaxel 134Carboplatin 129Bevacizumab 86Gemcitabine 45pembrolizumab 37olaparib 33Cisplatin 30liposomal doxorubicin 29Docetaxel 29Cyclophosphamide 29Topotecan 28niraparib 27Taxes 20Etoposide 18Filgrastim 16Doxorubicin 16Immunoglobulin G 15Disulfides 15apatinib 12Letrozole 12Albumin-Bound Paclitaxel 12Drug Therapy 11fluzoparib 10fludarabine 10Specimen Handling 10Magnetic Resonance Spectroscopy 10Biopsy 10durvalumab 9Nivolumab 9pazopanib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Ovarian Neoplasms × Mitoxantrone × Clear all
NCT00002474 2013-05-30

Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡